FluoRok, an Oxford, UK-based fluorochemical manufacturing startup, has raised $30 million (£22.8 million) in an oversubscribed Series A financing round led by Orano Venture Fund and Supernova Invest, with investment from Bidra Innovation Ventures.
Existing investors Oxford Science Enterprises, BGF, Green Generation Fund (GGF), Volta Energy Technologies and the University of Oxford also participated. Additional backing came from EverQuest Capital Partners, CPI Enterprises, WS Investment and angel investors. The financing included approximately $1.3 million (£1 million) in grant funding from Innovate UK through its Investor Partnerships programme.
Founded in 2022 by Dr Gabriele Pupo and Professor Véronique Gouverneur, FluoRok is a University of Oxford spinout developing an alternative process for manufacturing fluorochemicals. Pupo serves as CEO, while Gouverneur, a professor of chemistry at Oxford, serves as an adviser and non-executive director.
The company’s patented technology uses mechanical activation to produce fluorochemicals without relying on hydrogen fluoride (HF), a highly hazardous substance commonly used in conventional manufacturing. Its process can operate on standard industrial equipment and use lower-grade mined fluoride or fluoride recovered from industrial waste streams.
FluoRok is initially targeting the production of inorganic fluorides for pharmaceutical and agrochemical applications, alongside lithium hexafluorophosphate (LiPF₆), an electrolyte salt used in lithium-ion batteries.
The new funding will support FluoRok’s transition from pilot-scale operations to industrial manufacturing. The company plans to establish demonstrator facilities for fluorochemical reagents and battery electrolyte salts, expand its workforce, conduct larger-scale product validation with customers and develop additional commercial partnerships.
FluoRok reported that it had completed pilot qualifications as part of its commercial development. The company also disclosed $14 million (£11 million) raised through previous financing rounds and more than $13 million (£10 million) secured through UK and European public funding programmes.
The Series A follows FluoRok’s earlier financing in 2024, which was led by BGF and Green Generation Fund. The latest investment will support the company’s efforts to establish repeatable industrial-scale production of fluorochemicals for its target markets.

